NEWS
Scroll Down
2023-02-24
Notice of Completion of Series A Funding of Approximately 560 Million Yen
CTBE has completed Series A Funding in January 2023. A total of approximately 560 million yen in series A funding was raised through the following investors.
Waseda Innovation Fund No. 3 Investment Partnership
Teijin Limited
Japan Science and Technology Agency
AXA Life Insurance Co., Ltd.
NextG Investment Business Limited Liability Partnership
Sun Global Co., Ltd.
With this funding, CTBE will accelerate the commercialization of artificial ligaments for anterior cruciate ligament reconstruction surgery.
RECNET NEWS
2026-01-13
CTBE and Microwave Chemical Begin Developing Mass-Production Equipment for a Novel “Regenerative Ligament” for ACL Reconstruction
2026-01-09
CTBE has been selected for the 8th NEDO-DTSU Support Project (Grant).
2025-11-10
CoreTissue BioEngineering Raises New Funding of ¥600 Million: Nippon Ham and Mitsui Sumitomo Insurance Capital Join as New Shareholders
2025-06-02
CEO Jokura will be speaking at the public seminar at the 100th Japan Society of Medical Devices / Conference Medical Show Japan & Business Expo 2025
2025-04-01
Notice of changes to the president and executive officers
TOP
